LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Ensemble-based virtual screening of African natural products to target human thymidylate synthase.

    Mteremko, Denis / Chilongola, Jaffu / Paluch, Andrew S / Chacha, Musa

    Journal of molecular graphics & modelling

    2023  Volume 125, Page(s) 108568

    Abstract: Human thymidylate synthase (hTS) is a validated drug target for chemotherapy. A virtual screening experiment was used to prioritize a list of compounds from African Natural Products Databases docked against the orthosteric binding pocket of hTS. ... ...

    Abstract Human thymidylate synthase (hTS) is a validated drug target for chemotherapy. A virtual screening experiment was used to prioritize a list of compounds from African Natural Products Databases docked against the orthosteric binding pocket of hTS. Consensus scores of binding affinities from ensemble-based virtual screening, hydrated docking and MM-PBSA calculations ranked compounds NEA4433 and NEA4434 as the best candidates owing to binding affinity scores in the picomolar order, their excellent ADMET profiles and the good stability of the protein-ligand complexes formed. The current study demonstrates the role of water in small molecule binding to hTS in mediating protein-ligand interactions. Similarly, the robust ensemble docking (relaxed scheme complex) ranked NEA4433 and NEA4434 as the best candidates. Furthermore, the best candidates prioritized were shown to strongly interact with the same residues that interacted with hTS substrate and cofactor.
    MeSH term(s) Humans ; Thymidylate Synthase/chemistry ; Molecular Docking Simulation ; Ligands ; Protein Binding
    Chemical Substances Thymidylate Synthase (EC 2.1.1.45) ; Ligands
    Language English
    Publishing date 2023-08-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1396450-1
    ISSN 1873-4243 ; 1093-3263
    ISSN (online) 1873-4243
    ISSN 1093-3263
    DOI 10.1016/j.jmgm.2023.108568
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Targeting human thymidylate synthase: Ensemble-based virtual screening for drug repositioning and the role of water.

    Mteremko, Denis / Chilongola, Jaffu / Paluch, Andrew S / Chacha, Musa

    Journal of molecular graphics & modelling

    2022  Volume 118, Page(s) 108348

    Abstract: A drug repositioning computational approach was carried to search inhibitors for human thymidylate synthase. An ensemble-based virtual screening of FDA-approved drugs showed the drugs Imatinib, Lumacaftor and Naldemedine to be likely candidates for ... ...

    Abstract A drug repositioning computational approach was carried to search inhibitors for human thymidylate synthase. An ensemble-based virtual screening of FDA-approved drugs showed the drugs Imatinib, Lumacaftor and Naldemedine to be likely candidates for repurposing. The role of water in the drug-receptor interactions was revealed by the application of an extended AutoDock scoring function that included the water forcefield. The binding affinity scores when hydrated ligands were docked were improved in the drugs considered. Further binding free energy calculations based on the Molecular Mechanics Poisson-Boltzmann Surface Area method revealed that Imatinib, Lumacaftor and Naldemedine scored -130.7 ± 28.1, -210.6 ± 29.9 and -238.0 ± 25.4 kJ/mol, respectively, showing good binding affinity for the candidates considered. Overall, the analysis of the molecular dynamics trajectory of the receptor-drug complexes revealed stable structures for Imatinib, Lumacaftor and Naldemedine, for the entire simulation time.
    MeSH term(s) Humans ; Drug Repositioning/methods ; Molecular Docking Simulation ; Thymidylate Synthase ; Water/chemistry ; Imatinib Mesylate ; Molecular Dynamics Simulation
    Chemical Substances lumacaftor (EGP8L81APK) ; Thymidylate Synthase (EC 2.1.1.45) ; Water (059QF0KO0R) ; Imatinib Mesylate (8A1O1M485B)
    Language English
    Publishing date 2022-10-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1396450-1
    ISSN 1873-4243 ; 1093-3263
    ISSN (online) 1873-4243
    ISSN 1093-3263
    DOI 10.1016/j.jmgm.2022.108348
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Finding alternatives to 5-fluorouracil: application of ensemble-based virtual screening for drug repositioning against human thymidylate synthase.

    Mteremko, Denis / Shadrack, Daniel M / Ntie-Kang, Fidele / Chilongola, Jaffu / Chacha, Musa

    Journal of biomolecular structure & dynamics

    2022  Volume 41, Issue 11, Page(s) 4873–4889

    Abstract: 5-fluorouracil and analogs are used in the treatment of many solid tumours. However, there are many cases of resistance and high toxicity associated with 5-fluorouracil chemotherapy. Repurposing FDA drugs against human thymidylate synthase revealed a ... ...

    Abstract 5-fluorouracil and analogs are used in the treatment of many solid tumours. However, there are many cases of resistance and high toxicity associated with 5-fluorouracil chemotherapy. Repurposing FDA drugs against human thymidylate synthase revealed a number of FDA drugs that have a potential to be further developed for the treatment of various cancers for which 5-fluorouracil and analogs have been used for chemotherapy. Four FDA drugs prioritized for further validation included Erismodegib, Irinotecan, Conivaptan and Ergotamine. The role of water in mediating drug interactions and its contribution to the total binding energy was also shown. MM-PBSA calculations revealed that the binding affinity was the lowest for the hTS-Ergotamine complex (-66.702 ± 1.807 kJ/mol) suggesting moderate inhibition despite a large energetic contribution from van der Waal interactions (-190.889 ± 1.027 kJ/mol).Communicated by Ramaswamy H. Sarma.
    MeSH term(s) Humans ; Fluorouracil/pharmacology ; Drug Repositioning ; Thymidylate Synthase ; Neoplasms/drug therapy ; Ergotamines
    Chemical Substances Fluorouracil (U3P01618RT) ; Thymidylate Synthase (EC 2.1.1.45) ; Ergotamines
    Language English
    Publishing date 2022-05-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 49157-3
    ISSN 1538-0254 ; 0739-1102
    ISSN (online) 1538-0254
    ISSN 0739-1102
    DOI 10.1080/07391102.2022.2074140
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top